It has been demonstrated that CDK1 positively regulates the type I IFN signaling pathway in SLE, facilitating the development of severe disease and contributing to the concept that CDKs impact on IFN response may pass through STAT1 phosphorylation, as already demonstrated for CDK8. Here, CDK1 is linked to systemic lupus erythematosus.